Home
Site Search
Use small fonts Use medium fonts Use large fonts Email link to page PDF this page

Tayyaba Khan Picture

Email to Tayyaba Khan Tayyaba Khan

Associate

OfficeToronto

t: 416 860 6589
f: 416 360 8877
e: send email

Suite 2100, Scotia Plaza
40 King Street West
Toronto, ON  M5H 3C2
Canada

Download vCard

Expertise

Year of Call

Ontario, 2014

Education

J.D., University of Ottawa, 2013

B.A., York University, 2010

 

Tayyaba Khan

Tayyaba Khan is an associate in our Business Law Group, specializing in corporate and securities law matters. In her practice, Tayyaba advises public and private companies, partnerships, start-ups and entrepreneurs in matters related to mergers and acquisitions and corporate finance, including private and public securities offerings, corporate governance, private equity and venture capital transactions, as well as all other aspects of corporate and securities law.

Tayyaba routinely advises cannabis companies, including licensed producers, retail operators and ancillary businesses, with respect to strategic transactions as well as day-to-day securities compliance, disclosure and corporate governance matters. Her experience in the industry includes M&A transactions for Canadian companies pursuing global expansion in the United States, Denmark, Germany and Latin America. Tayyaba also has experience working with investors as well as technology companies at all stages of development in connection with matters relating to incorporation, organization and acting on a variety of transactions, including private equity financings and exit transactions. 

Prior to joining Cassels Brock, Tayyaba worked in the Ottawa office of another national law firm and has been involved in numerous precedent setting transactions in the cannabis industry in her capacity as counsel to Canopy Growth Corporation, including: a $5 billion investment by Constellation Brands, Inc.; a $200 million prospectus offering, the first equity financing transaction to be led by a Schedule 1 bank; the acquisitions of Bedrocan Cannabis Corp., Mettrum Health Corp. and ebbu Inc., among others; the completion of Canopy’s qualifying transaction to list on the TSX Venture Exchange; and its graduation to the Toronto Stock Exchange.